Company: STAA
Filing Date: 2025-08-29
Form Type: PREM14A
Source: 0001193125-25-192889
Chunk: 38

Company: STAAR SURGICAL CO
Filing Date: 2025-08-29
Form: PREM14A
Chunk 38
---
% of STAAR’s outstanding shares of STAAR common stock. If STAAR’s largest investors do not vote their shares in support of the adoption of the Merger Agreement, STAAR’s ability to satisfy this closing condition would be materially adversely affected. In addition, the consummation of the Merger is subject to the expiration or termination of the applicable waiting period (and any extension thereof) under the HSR Act (which waiting period will expire on -23-

2025 at 11:59 p.m., Eastern Time, unless otherwise earlier terminated or extended), as well as of any agreement not to close embodied in a “timing agreement” between the parties and a
governmental body, and the receipt of regulatory approvals in other jurisdictions, including China and Japan among others. The relevant governmental entities may impose requirements, limitations or costs or place restrictions on the conduct of
STAAR’s or Alcon’s business following the Merger as a condition to approval or not grant approval at all.

Other conditions
that must be satisfied or waived before one or more of the parties will be obligated to consummate the Merger are (1) the accuracy of the other party’s representations and warranties, subject to certain materiality standards set forth in
the Merger Agreement; (2) compliance by the other party in all material respects with such other party’s obligations and covenants under the Merger Agreement; (3) the absence of any law or order prohibiting consummation of the Merger
or that that makes illegal the consummation of the Merger in specified jurisdictions in which STAAR, Alcon or their respective subsidiaries have business operations; and (4) in the case of Alcon’s and Merger Sub’s obligation to
consummate the Merger, the absence of a Material Adverse Effect (as defined in “The Merger Agreement—Representations and Warranties”) on STAAR since the date of the Merger Agreement that is continuing.

STAAR can provide no assurance that the closing conditions will be fulfilled (or waived, if applicable) in a timely manner or at all, and, if
all closing conditions are timely fulfilled (or waived, if applicable), STAAR can provide no assurance as to the terms, conditions, and timing of the completion of the Merger. Many of the conditions to consummation of the Merger are not within
either STAAR’s, Alcon’s or Merger Sub’s control, and STAAR cannot predict when or if these conditions will be fulfilled (or